Watch a webinar as experts on tenosynovial giant cell tumor (TGCT) share an overview of TGCT and a simple summary of the MOTION study. ROMVIMZA is a prescription medicine used to treat adults with ...

Systemic therapy and active surveillance can be viable options for patients with TGCT, as one expert explained. Sydney Stern has undergone six surgeries for TGCT, or tenosynovial giant cell tumors.

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue that ...

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve ...